Study: Abortion Rates Amongst Teens Slashed with Free Contraceptives

Leslie Carol Botha: The media reported today that a new study shows that free contraceptives reduces rates of  unintended pregnancies and rates of abortion amongst teens. The study reported that ‘there were 6.3 births per 1,000 teenagers in the study, compared with a national rate of 34 births per 1,000 teens in 2010.

Although this may at first, sound like a good piece of news -it is a strong push for using synthetic hormones in IUD’s, Depo Provera injections , and Nexplanon implants for teenage girls. This is actually quite frightening to the health of young girls. They are being administered at the most fragile and critical time of adolescents lives – menarche- when their endocrine system is beginning to develop its own rhythm.

Hormone imbalance is already rampant. Mothers are passing synthetic estrogen in utero. Excess estrogen is excreted into the bloodstream affecting the sex of fish.

If you want to read how many women are suffering hormone imbalance and the struggle women are having after being on synthetic hormones read the over 200 comments posted to this article Hormonal Imbalance Anxiety a Precursor to Other Health Issues.

  • Where is the accountability of the boys and men in our lives?
  • Who is the sponsor of this study? Pharma?
  • How will this affect these girl’s future fertility? Especially since synthetic hormones deplete nutrients.
  • Girls and women will also need to use condoms and spermicide to protect them from STD’s. Will they?

Girls be aware. This could very well be a wolf in sheep’s clothing. Nothing is for free.


Study: Free Birth Control Slashes Abortion Rates

Time Healthland
By Olivia B. Waxman
October 5, 2012

Spike Mafford / Getty Images

What would happen if women at risk for unintended pregnancies received the birth control of their choice — especially the more effective kinds — at no cost?

The national abortion rate would plummet, according to a study conducted by researchers at the Washington University School of Medicine in St. Louis and published in the journal Obstetrics & Gynecology on Thursday.

The researchers enrolled 9,256 women from the St. Louis region into the Contraceptive Choice Project between August 2007 and September 2011. The women were aged 14 to 45, with an average age of 25, and many were poor and uninsured with low education. Nearly two-thirds had had an unintended pregnancy previously. Participants were either not using a reversible contraception method or willing to switch to a new one.

Researchers provided free, FDA-approved birth control to the women for three years. The women were given their choice of contraception, including oral birth control pills and long-acting reversible contraceptive (LARC) methods like implants and IUDs. The researchers specially briefed the participants on the “superior effectiveness” of LARC methods — the T-shaped IUD, or intrauterine device, has close to 100% effectiveness and can last five to 10 years, for instance — and 75% of women chose those devices over the pill, patch or ring.

Over the course of the study, which lasted from 2008 to 2010, women experienced far fewer unintended pregnancies than expected: there were 4.4 to 7.5 abortions per 1,000 women in the study, after adjusting for age and race — much fewer than the national rate of 19.6 abortions per 1,000 women and lower also than the rate in the St. Louis area of 13.4 to 17 abortions per 1,000 women.

The effect of free contraception on the teen birth rate was remarkable: there were 6.3 births per 1,000 girls aged 15 to 19 in the study, compared with the national rate of 34.3 births per 1,000 teen girls.


Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.